Clinical Trial Update: Ultrasound to Predict Steal-Syndrome After Arteriovenous-Fistula Creation (UPSAC - Trial)

View source ↗

Summary

The UPSAC trial, investigating ultrasound to predict steal syndrome after arteriovenous fistula creation in chronic kidney disease patients, has been withdrawn …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: Baptist Health South Florida | Conditions: Chronic Kidney Disease | Status: WITHDRAWN